1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow INCB 54828-101: new trials by email Literature Review of INCB 54828-101 trials Research Report on INCB 54828-101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration Pemigatinib - Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | Completed | Incyte Corporation | 8 | 2022-04-29 | 2025-08-05 |
Acrocephalosyndactylia (1) · Carcinoma, Non-Small-Cell Lung (1) · Recurrence (1)
France (1) · Germany (1) · Italy (1) · Spain (1) · United States (1)